Manoussos Perros - 19 Oct 2021 Form 4 Insider Report for Entasis Therapeutics Holdings Inc.

Role
President and Chief Executive Officer, Director
Signature
Mary Stack as Attorney-in-Fact for Manoussos Perros
Issuer symbol
N/A
Transactions as of
19 Oct 2021
Net transactions value
-$38,197
Form type
4
Filing time
20 Oct 2021, 16:14:32 UTC
Previous filing
15 Feb 2022
Next filing
03 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ETTX Common Stock Award $0 +79,750 +100% $0.000000 159,500 19 Oct 2021 Direct F1
transaction ETTX Common Stock Sale $38,197 -11,974 -7.5% $3.19 147,526 19 Oct 2021 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Acquired as a result of the satisfaction of the performance criteria of the underlying award as of the date stated. Fifty percent of this award vested on such date and the remaining fifty percent will vest on the first anniversary of such date, subject to the reporting person's continued employment with the Company.
F2 Represents shares sold solely for purposes of the payment of taxes arising in connection with the vesting of restricted stock units on October 19, 2021. The number of shares sold was determined based on the closing price on the last trading day prior to vesting, which was October 18, 2021.

Remarks:

President and Chief Executive Officer